UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Catalyst-Controlled Switch in Chemo- and Diastereoselectivities: Annulations of Morita-Baylis-Hillman Carbonates from Isatins

Angewandte Chemie International Edition, 2016-02, Vol.55 (6), p.2147-2151

International ed. in English, 2016

Volltextzugriff (PDF)

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

Liver cancer (Basel ), 2020-06, Vol.9 (3), p.245-260

2020

Volltextzugriff (PDF)

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Hepatology (Baltimore, Md.), 2014-11, Vol.60 (5), p.1697-1707

2014

Volltextzugriff (PDF)

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Clinical cancer research, 2018-01, Vol.24 (1), p.73-83

2018

Volltextzugriff (PDF)

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

JNCI : Journal of the National Cancer Institute, 2009-10, Vol.101 (19), p.1348-1355

2009

Volltextzugriff (PDF)

Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase

Hepatology (Baltimore, Md.), 2019-04, Vol.69 (4), p.1412-1425

2019

Volltextzugriff (PDF)

Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

Hepatology (Baltimore, Md.), 2009-06, Vol.49 (6), p.1859-1867

2009

Volltextzugriff (PDF)

Direct Asymmetric Aza‐Vinylogous‐Type Michael Additions of Nitrones from Isatins to Nitroalkenes

Chemistry : a European journal, 2017-05, Vol.23 (26), p.6286-6289

2017

Volltextzugriff (PDF)

A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness

PloS one, 2021-03, Vol.16 (3), p.e0249003

2021

Volltextzugriff (PDF)

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.7077-7089

2023

Volltextzugriff (PDF)

Genome‐wide association analysis identifies a GLUL haplotype for familial hepatitis B virus‐related hepatocellular carcinoma

Cancer, 2017-10, Vol.123 (20), p.3966-3976

2017

Volltextzugriff (PDF)

AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review

Liver cancer (Basel ), 2022-04, Vol.11 (2), p.94-112

2022

Volltextzugriff (PDF)

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

Hepatology international, 2010-06, Vol.4 (2), p.439-474

2010

Volltextzugriff (PDF)

Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience

Cancer medicine (Malden, MA), 2023-07, Vol.12 (14), p.14902-14911

2023

Volltextzugriff (PDF)

Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma

European radiology, 2021-11, Vol.31 (11), p.8649-8661

2021

Volltextzugriff (PDF)

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Journal of hepatology, 2007-01, Vol.46 (1), p.45-52

2007

Volltextzugriff (PDF)

Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment

Journal of the Formosan Medical Association, 2024-07, Vol.123 (7), p.788-795

2024

Volltextzugriff (PDF)

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

Cancer medicine (Malden, MA), 2022-10, Vol.11 (20), p.3786-3795

2022

Volltextzugriff (PDF)

Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations

Abdominal radiology (New York), 2019-03, Vol.44 (3), p.1141-1151

2019

Volltextzugriff (PDF)

Influences of tobacco and alcohol use on hepatocellular carcinoma survival

International journal of cancer, 2012-12, Vol.131 (11), p.2612-2621

2012

Volltextzugriff (PDF)

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening

Hepatology (Baltimore, Md.), 2015-06, Vol.61 (6), p.1934-1944

2015

Volltextzugriff (PDF)

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis

PloS one, 2018-08, Vol.13 (8), p.e0202777

2018

Volltextzugriff (PDF)

Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B‐related hepatocellular carcinoma

Molecular carcinogenesis, 2020-11, Vol.59 (11), p.1269-1279

2020

Volltextzugriff (PDF)

Experimental and Numerical Analysis on the Impact Wear Behavior of TP316H Steel

Materials, 2022-04, Vol.15 (8), p.2881

2022

Volltextzugriff (PDF)

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2016-09, Vol.64 (3), p.720-731

2016

Volltextzugriff (PDF)

1 – 25 von 697

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(598)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(629)
Chinesisch
(69)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Catalyst-Controlled Switch in Chemo- and Diastereoselectivities: Annulations of Morita-Baylis-Hillman Carbonates from Isatins

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase

Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

Direct Asymmetric Aza‐Vinylogous‐Type Michael Additions of Nitrones from Isatins to Nitroalkenes

A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma

Genome‐wide association analysis identifies a GLUL haplotype for familial hepatitis B virus‐related hepatocellular carcinoma

AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real‐world experience

Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations

Influences of tobacco and alcohol use on hepatocellular carcinoma survival

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis

Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B‐related hepatocellular carcinoma

Experimental and Numerical Analysis on the Impact Wear Behavior of TP316H Steel

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma

Suchergebnisse filtern